Great Point Partners LLC
41 holdingsFiling period: 2026-06-30Current AUM: $440.1Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ABVX | Abivax SA | 604.3K | $80.5M | $54.3M | 12.33% | -- | 2026-06-30 |
| 2 | VOR | Vor Biopharma Inc | 1.70M | $31.3M | $35.1M | 7.98% | -50,000 | 2026-06-30 |
| 3 | IBRX | Immunitybio Inc | 3.00M | $26.3M | $26.4M | 6.01% | -- | 2026-06-30 |
| 4 | VERA | Vera Therapeutics Inc | 600.8K | $25.8M | $18.6M | 4.22% | +401.5K | 2026-06-30 |
| 5 | — | Zura Bio Ltd | 4.22M | $24.9M | $24.9M | 5.65% | -- | 2026-06-30 |
| 6 | ALMS | Alumis Inc | 856.1K | $24.1M | $6.1M | 1.39% | -- | 2026-06-30 |
| 7 | — | Sol-Gel Technologies Ltd | 274.4K | $20.3M | $20.3M | 4.62% | -- | 2026-06-30 |
| 8 | RARE | Ultragenyx Pharmaceutical in | 600.0K | $20.0M | $10.3M | 2.34% | -- | 2026-06-30 |
| 9 | DFTX | Definium Therapeutics Inc | 425.0K | $20.0M | $16.2M | 3.68% | -- | 2026-06-30 |
| 10 | ANNX | Annexon Inc | 3.50M | $20.0M | $14.1M | 3.21% | +1.00M | 2026-06-30 |
| 11 | ORKA | Oruka Therapeutics Inc | 183.3K | $17.4M | $17.6M | 4.00% | -- | 2026-06-30 |
| 12 | MLTX | Moonlake Immunotherapeutics | 855.8K | $16.7M | $10.5M | 2.39% | +355.8K | 2026-06-30 |
| 13 | SGMT | Sagimet Biosciences Inc | 2.03M | $15.7M | $21.8M | 4.95% | -- | 2026-06-30 |
| 14 | CTNM | Contineum Therapeutics Inc | 921.5K | $15.1M | $8.4M | 1.92% | +121.3K | 2026-06-30 |
| 15 | IMMX | Immix Biopharma Inc | 1.28M | $13.2M | $10.4M | 2.36% | +927.6K | 2026-06-30 |
| 16 | CLYM | Climb Bio Inc | 1.00M | $13.0M | $10.1M | 2.30% | -334,130 | 2026-06-30 |
| 17 | AMLX | Amylyx Pharmaceuticals Inc | 700.0K | $12.6M | $19.6M | 4.46% | -1,050,000 | 2026-06-30 |
| 18 | NKTR | Nektar Therapeutics | 175.0K | $12.2M | $6.7M | 1.53% | -141,453 | 2026-06-30 |
| 19 | NGNE | Neurogene Inc | 352.2K | $11.1M | $10.7M | 2.43% | -147,820 | 2026-06-30 |
| 20 | LBRX | LB Pharmaceuticals Inc | 317.2K | $10.3M | $12.6M | 2.87% | +17.2K | 2026-06-30 |
| 21 | IRD | Opus Genetics Inc | 1.97M | $8.1M | $7.2M | 1.65% | +1.65M | 2026-06-30 |
| 22 | EPRX | Eupraxia Pharmaceuticals Inc | 1.20M | $7.9M | $8.9M | 2.01% | -- | 2026-06-30 |
| 23 | DRUG | Bright Minds Biosciences Inc | 109.6K | $7.7M | $6.1M | 1.38% | -110,397 | 2026-06-30 |
| 24 | — | Inflarx NV | 3.05M | $6.8M | $6.8M | 1.55% | -- | 2026-06-30 |
| 25 | RLMD | Relmada Therapeutics Inc | 842.1K | $5.8M | $2.8M | 0.64% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2